Reactive arthritis as a musculoskeletal manifestation of COVID-19

Authors

  • Carlos Fabián Padilla Universidad Nacional de Chimborazo https://orcid.org/0000-0002-7858-4494
  • Ariel Josué Tapia Verdezoto Universidad Nacional de Chimborazo
  • Brigitte Carolina Fiallos Rivas Universidad Nacional de Chimborazo
  • Erika Jazmín Pinto Matos Universidad Nacional de Chimborazo
  • Vanessa Stephanie Galeas Jati Universidad Nacional de Chimborazo

Keywords:

reactive arthritis, COVID-19, joint inflammation, clinical manifestations

Abstract

COVID-19 or coronavirus disease is an infectious disease caused by the SARS-COV2 virus, with multiple clinical manifestations; being fever, cough and dyspnea the most prevalent. However, other manifestations are reported as part of the disease, including rheumatological ones. We present the case of a 28-year-old male patient who presented with pain and inflammation in both knees that limited ambulation. With a history of respiratory infection (COVID-19) about 21 days ago in which he presented light respiratory manifestations. The clinical manifestations, maneuvers performed and results of complementary examinations; among them, the finding of synovial fluid with inflammatory characteristics confirmed the diagnosis of reactive arthritis as part of the expression of COVID-19. Appropriate treatment was implemented and the patient evolved satisfactorily. The objective of this report is to describe the presence of reactive arthritis secondary to SARS-COV2 infection, establishing its relationship by describing a clinical case. We proceeded to write up the positive clinical findings in the aforementioned patient. In addition, an active and updated search in scientific data sources to establish the relationship between these two entities. It is concluded that it is necessary to consider the expression of reactive arthritis in patients who have presented COVID-19; as interrelated diseases, which should not be viewed as separated entities.

Downloads

Download data is not yet available.

Author Biographies

Carlos Fabián Padilla, Universidad Nacional de Chimborazo

Estudiante de medicina

Ariel Josué Tapia Verdezoto, Universidad Nacional de Chimborazo

Estudiante de medicina

Brigitte Carolina Fiallos Rivas, Universidad Nacional de Chimborazo

Estudiante de medicina

Erika Jazmín Pinto Matos, Universidad Nacional de Chimborazo

Estudiante de medicina

Vanessa Stephanie Galeas Jati, Universidad Nacional de Chimborazo

Estudiante de medicina

References

Cruz-Martínez J. Artritis reactiva. Medicine. 2001 [Acceso 15/08/2021];8(31):1616–1621. Disponible en: https://www.medicineonline.es/es-pdf-S0304541201703101?referer=seccion

Bohórquez Heras C, Movasat Hadjkan A, Turrión Nieves A, Pérez A. Artritis reactiva. Medicine. 2017 [Acceso 15/08/2021];12(26):1498-1507. Disponible en: https://www.sciencedirect.com/science/article/pii/S0304541217300161

Baimukhamedov C, Barskova T, Matucci-Cerinic M. Arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021 [Acceso 10/09/2021];3(5):e324–5. Disponible en: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(21)00067-9/fulltext

Zeidler H. Post-Corona-Virus-Disease‑19 arthritis. Manifestation under the clinical picture of a reactive arthritis. Z Rheumatol. 2021[Acceso 28/07/2021];80(6):555–8. Disponible en: https://link.springer.com/article/10.1007%2Fs00393-021-01045-9

García A, Medina E, Martínez J, Mestre , Moliner M. Active inquiry of symptomatic respiratory patients essence of COVID-19 prevention. Rev.Med.Electrón. 2020 [Acceso 14/10/2021];42(2):1709-1712. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1684-18242020000201709&script=sci_arttext&tlng=en

Echeverría R, Sueyoshi H. Situación epidemiológica del COVID-19 en Sudamérica. Rev. Fac. Med. Hum. 2020 [Acceso 14/10/2021];20(3):525-527. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2308-05312020000300525

Haro AS, Calderón EP. Caracterización epidemiológica de Covid-19 en Ecuador. InterAm J Med Health. 2020 [Acceso 14/10/2021];3:e202003020. Disponible en: https://iajmh.emnuvens.com.br/iajmh/article/view/99/110

Li, Long-Quan et al. COVID-19 Patients’ Clinical

Characteristics, Discharge Rate, and Fatality Rate of Meta-Analysis. J Med Virol. 2020. [Acceso: 14/10/2021] 92.6. 577–583. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228329/

Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Características clínicas, de laboratorio y de imágenes de COVID-19: una revisión sistemática y un metanálisis. Travel Med Infect Dis . 2020. [Acceso: 20/10/2021]. 34: 101623. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102608/

Sun P, Qie S, Liu Z, Ren J, Li K, Xi J. Características clínicas de los pacientes hospitalizados con infección por SARS-CoV-2: un metanálisis de un solo brazo. J Med Virol. 2020. [Acceso:20/10/2021];92(6):612-617. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228255/

Solís U, Valdés J, Hernández W, Garofalo A, Rodríguez , Gafas. Rol de las Manifestaciones Reumáticas y Dermatológicas en el Diagnóstico de COVID-19 en Pacientes Paucisintomáticos. Rev. de Investigación Talentos. 2020 [Acceso: 18/10/2021];7(2):74-83. Disponible en: https://talentos.ueb.edu.ec/index.php/talentos/article/view/217

Valverde AJS, Temoche CEM, Caicedo CRC, Hernández NBA, Padilla TMT. Covid-19: fisiopatología, historia natural y diagnóstico. REVISTA EUGENIO ESPEJO. 2021 [Acceso 10/10/2021];15(2):98–114. Disponible en: https://eugenioespejo.unach.edu.ec/index.php/EE/article/view/223

Ono K, Kishimoto M, Shimasaki T, Uchida H, Kurai D, Deshpande GA, et al. Reactive arthritis after COVID-19 infection. RMD Open. 2020 [Acceso 28/07/2021];6(2):e001350. Disponible en: https://rmdopen.bmj.com/content/6/2/e001350

Solis-Cartas U, Valdés-González J, Hernandez-Perdomo W, Martinez-Larrarte J. Manifestaciones reumáticas y dermatológicas en pacientes paucisintomáticos de COVID-19. globalrheumpanlar. 2021 [Acceso 17/10/2021]:1-24. Disponible en: http://www.globalrheumpanlar.org/manuscrito-articulo-original/manifestaciones-reumaticas-y-dermatologicas-en-pacientes?title=&language=en&page=4

López JR, Ortiz KA, Carrión WG, Castillo JB. La artritis reactiva al virus de Epstein Barr. Medigraphic.com. [Acceso 25 /10/2021]; 18(3): 287 - 290. Disponible en: https://www.medigraphic.com/pdfs/revcubreu/cre-2016/cre163i.pdf

Bohórquez Heras C, Movasat Hadjkan A, Pérez A, Turrión Nieves A. Protocolo diagnostico de la oligoartritis. Medicine. 2017 [Acceso 17/10/2021]; 12(26). 1530-1534. Disponible en: https://www.medicineonline.es/es-protocolo-diagnostico-oligoartritis-articulo-S0304541217300197

Published

2021-12-21

How to Cite

1.
Padilla CF, Tapia Verdezoto AJ, Fiallos Rivas BC, Pinto Matos EJ, Galeas Jati VS. Reactive arthritis as a musculoskeletal manifestation of COVID-19. Rev. cuba. de Reumatol. [Internet]. 2021 Dec. 21 [cited 2025 Feb. 7];23(1 Suppl 1):e255. Available from: https://revreumatologia.sld.cu/index.php/reumatologia/article/view/972